Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Week in Review: Osaka Enters $445 Million Deal for Two Hearing Loss Candidates from France's Cilcare

XtalPi Stages $127 Million IPO in Hong Kong for AI Drug Discovery

Takeda Signs $100 Million Option for Ascentage’s Lead TKI Therapy

Nanjing Biosion Reports anti-TSLP mAb Effective for Atopic Dermatitis

Shionogi Options Two Hearing Loss Therapies in Deal Worth 415 Million Euros

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital